Genesys Ventures II LP 13D and 13G filings for Profound Medical Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:21 pm Sale | 2021-12-31 | 13G | Profound Medical Corp. PROF | Genesys Ventures II LP | 455,738 2.190% | -153,745 (-25.23%) | Filing |
| 2021-02-16 4:35 pm Sale | 2020-12-31 | 13G | Profound Medical Corp. PROF | Genesys Ventures II LP | 609,483 3.110% | -300,604 (-33.03%) | Filing |
| 2020-04-30 5:29 pm Purchase | 2019-12-31 | 13G | Profound Medical Corp. PROF | Genesys Ventures II LP | 910,087 7.680% | 910,087 (New Position) | Filing |